Eric Zhu

866 total citations
12 papers, 277 citations indexed

About

Eric Zhu is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eric Zhu has authored 12 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eric Zhu's work include Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Eric Zhu is often cited by papers focused on Immune Cell Function and Interaction (5 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Eric Zhu collaborates with scholars based in United States, India and Germany. Eric Zhu's co-authors include Monique J. Kauke, K. Dane Wittrup, Cary F. Opel, Kelly D. Moynihan, Byron H. Kwan, Alessandro Angelini, Glenn Dranoff, S. Annie Gai, Martín C. Mihm and Louis M. Weiner and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Chemistry of Materials.

In The Last Decade

Eric Zhu

8 papers receiving 273 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Zhu United States 5 176 134 61 54 48 12 277
Monique J. Kauke United States 8 428 2.4× 245 1.8× 211 3.5× 123 2.3× 94 2.0× 11 658
Yohana C. Toner United States 5 127 0.7× 119 0.9× 100 1.6× 32 0.6× 69 1.4× 7 341
Yongmei Ding China 9 97 0.6× 257 1.9× 178 2.9× 19 0.4× 124 2.6× 13 440
Yihua Cai United States 8 116 0.7× 121 0.9× 93 1.5× 7 0.1× 38 0.8× 26 260
Tatiana Pazina United States 8 216 1.2× 156 1.2× 144 2.4× 33 0.6× 88 1.8× 10 460
Michelle L. Bookstaver United States 9 159 0.9× 63 0.5× 142 2.3× 28 0.5× 120 2.5× 10 361
Mingliang Fan China 7 129 0.7× 142 1.1× 131 2.1× 27 0.5× 75 1.6× 11 346
Manman Xue China 7 185 1.1× 161 1.2× 137 2.2× 12 0.2× 30 0.6× 10 373
Armin Ahmadi United States 12 153 0.9× 126 0.9× 233 3.8× 14 0.3× 120 2.5× 23 511
Jingyi Qiu United States 10 80 0.5× 39 0.3× 117 1.9× 38 0.7× 54 1.1× 20 316

Countries citing papers authored by Eric Zhu

Since Specialization
Citations

This map shows the geographic impact of Eric Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Zhu more than expected).

Fields of papers citing papers by Eric Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Zhu. The network helps show where Eric Zhu may publish in the future.

Co-authorship network of co-authors of Eric Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Zhu. A scholar is included among the top collaborators of Eric Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Zhu. Eric Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rubio, Daniel, et al.. (2025). Preclinical Safety of APG777, A Novel Extended Half-Life Anti-Interleukin-13 Monoclonal Antibody, in Cynomolgus Monkeys. International Journal of Toxicology. 44(6). 443–450.
3.
Zhu, Eric, et al.. (2025). In vitro potency and pharmacokinetics of APG777, a novel anti–IL-13 mAb. Journal of Allergy and Clinical Immunology Global. 4(4). 100545–100545.
4.
Zhu, Eric, et al.. (2024). APG777, a Humanized IgG1 Monoclonal Antibody, Binds to IL-13 with High Affinity and Potently Blocks IL-13 Signaling in Multiple in vitro Assays. SKIN The Journal of Cutaneous Medicine. 8(1). s314–s314. 2 indexed citations
5.
Zhu, Eric, et al.. (2024). APG777, a High-Affinity Humanized IgG1 Monoclonal Antibody Targeting IL-13, Demonstrates Prolonged Half-Life in Non-Human Primates. SKIN The Journal of Cutaneous Medicine. 8(1). s315–s315. 1 indexed citations
6.
Zhu, Eric, Daniël Blom, Shalini Sethumadhavan, et al.. (2020). 683 A novel mechanism of neuropilin-1 inhibition results in improved tumor growth inhibition in vivo. SHILAP Revista de lepidopterología. A410.1–A410. 1 indexed citations
7.
Zhu, Eric, et al.. (2018). Artificial Anti-Tumor Opsonizing Proteins with Fibronectin Scaffolds Engineered for Specificity to Each of the Murine FcγR Types. Journal of Molecular Biology. 430(12). 1786–1798. 7 indexed citations
8.
Su, Xiao, Monique J. Kauke, Jonathan C. Thomas, et al.. (2017). Redox Interfaces for Electrochemically Controlled Protein–Surface Interactions: Bioseparations and Heterogeneous Enzyme Catalysis. Chemistry of Materials. 29(13). 5702–5712. 39 indexed citations
9.
Kwan, Byron H., Eric Zhu, Alice Tzeng, et al.. (2017). Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses. The Journal of Experimental Medicine. 214(6). 1679–1690. 40 indexed citations
10.
Tzeng, Alice, Monique J. Kauke, Eric Zhu, et al.. (2016). Temporally Programmed CD8α+ DC Activation Enhances Combination Cancer Immunotherapy. Cell Reports. 17(10). 2503–2511. 41 indexed citations
11.
Zhu, Eric, S. Annie Gai, Cary F. Opel, et al.. (2015). Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2. Cancer Cell. 27(4). 489–501. 146 indexed citations
12.
Drake, Adam, Nikhil S. Joshi, Gregory L. Szeto, et al.. (2013). Koch Institute Symposium on Cancer Immunology and Immunotherapy. Cancer Immunology Research. 1(4). 217–222.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026